Clinical trial finds no benefit from aspirin in preventing colorectal cancer recurrence
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
Yahoo Finance8d
Aspirin Industry Eyes $2.1 Billion Valuation by 2030: Tablets Will Continue to Dominate, Maintaining Around 60-65% Market Share
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type" report has been ...